SLS Net Income Growth
Sellas Life Sciences Group Inc · Net Income Growth
SLS Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-23.62%period ending
SLS TTM Net Income YoY % (-33.61% → -23.62%)
Year-over-year change
High-resolution chart · PNG
SLS net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -23.6186% | |
| -8.5852% | |
| 13.0112% | |
| 19.6344% | |
| 23.7521% | |
| 24.2425% | |
| 17.2978% | |
| 15.773% | |
| 4.5482% | |
| -0.4347% | |
| 9.5906% | |
| 1.1682% | |
| 7.1085% | |
| -1.7523% | |
| -99.5314% | |
| -117.6461% | |
| -155.4489% | |
| -133.3356% | |
| -23.5245% | |
| 12.9179% | |
| 24.6867% | |
| 20.5366% | |
| 13.1402% | |
| 18.7966% | |
| 5.1447% | |
| 21.9478% | |
| 30.2783% | |
| -11.8629% | |
| 24.8154% | |
| 21.0075% | |
| 19.5031% | |
| 28.9755% | |
| 13.0746% | |
| -63.263% | |
| -45.968% | |
| 15.9052% | |
| 33.2753% | |
| 73.1251% | |
| 63.1477% | |
| 27.7276% | |
| -21.0336% | |
| -56.6055% | |
| -74.5643% | |
| 32.3677% | |
| 49.7589% | |
| 36.2037% | |
| 52.2601% | |
| -141.6406% | |
| -177.7143% | |
| -258.5508% | |
| -119.2742% | |
| -7.7593% | |
| -0.2046% | |
| 39.8136% | |
| -204.5815% | |
| -98.839% | |
| -112.6908% | |
| -171.1835% | |
| 4.2692% | |
| 8.6389% | |
| 10.5593% | |
| 33.9962% | |
| 34.7746% | |
| -0.431% | |
| 8.9971% | |
| -13.8634% | |
| -27.9274% | |
| -24.9711% | |
| -34.6235% | |
| -24.0384% | |
| -24.087% | |
| -33.6109% |